Ivan Solovyev presented Viriom’s plan on launching best in class HIV drugs in China – Elpida® – an effective, safe and well tolerated NNRTI with superior antiviral efficacy, resistance profile, pharmacokinetic properties, and VM1500A – a Long Acting Injectable Pre-Exposure Prophylaxis (PrEP).